Type of hormone replacement therapy and risk of venous thromboembolism

Editorial

Helen Roberts. BMJ. 2008.

. 2008 May 31;336(7655):1203-4.

doi: 10.1136/bmj.39556.666944.80. Epub 2008 May 20.

Abstract

Transdermal oestrogen may be safer than oral oestrogen

Competing interests: None declared.

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.
Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY. Canonico M, et al. BMJ. 2008 May 31;336(7655):1227-31. doi: 10.1136/bmj.39555.441944.BE. Epub 2008 May 20. BMJ. 2008. PMID: 18495631 Free PMC article.

1. Canonico M, Plu-Bureau G, Lowe GDO, Scarabin P-Y. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 2008; doi: 10.1136/bmj.39555.441944.BE - DOI - PMC - PubMed
1. Curb JD, Prentice RL, Bray PF, Langer RD, van Horn L, Barnabei VM, et al. Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch Intern Med 2006;166:772-80. - PubMed
1. Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SAA, Brzyski R, et al; for the WHI Investigators. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008;299:1036-45. - PubMed
1. Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Levesque H, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the Esther study. Circulation 2007;115:840-5. - PubMed
1. Smith N, Heckbert S, Lemaitre R, Reiner AP, Lumley T, Rosendaal FR, et al. Conjugated equine estrogens, esterified estrogens , prothrombotic variants and the risk of venous thrombosis in postmenopausal women. Arterioscler Thromb Vasc Biol 2006;26:2807-12. - PubMed